New-onset Afib is the most common complication after cardiac surgery, and the BoxX-NoAF clincial trial is exploring a proactive approach.

Discover more about the trial here: <a href="https://t.co/XtJ50uS8yc&quot; target="_blank">https://t.co/XtJ50uS8yc</a&gt;